Cormorant Asset Management, LLC
Q1 2014 13F-HR Holdings
Net value change ($000)
+90,308
(26.2%)
New positions
21
Sold out positions
12
Turnover %
49.2%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q4 2013
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| INTERCEPT PHARMACEUTICALS, INC. | 16,490 | NEW |
| PTCT | 13,888 | 2840.1% |
| JAZZ | 13,868 | NEW |
| BMRN | 13,428 | 190.9% |
| PRTA | 13,409 | NEW |
| MRK | 11,354 | NEW |
| BCRX | 10,320 | 506.6% |
| SRNE | 8,974 | NEW |
| ALKERMES PLC | 8,818 | NEW |
| RECEPTOS, INC. | 8,726 | 86.0% |
Top Reduces (Value $000, Stocks/ETFs)
| KERYX BIOPHARMACEUTICALS | -22,015 | -100.0% |
| CELG | -20,276 | -100.0% |
| BMY | -14,351 | -100.0% |
| GERN | -12,968 | -80.5% |
| ALNY | -12,718 | -79.1% |
| ACAD | -12,693 | -63.5% |
| Alkermes Plc | -6,099 | -100.0% |
| AMAG | -6,070 | -100.0% |
| CUBIST PHARMACEUTICALS INC | -5,603 | -20.3% |
| PODD | -5,565 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|